Timothy Sullivan
CFO
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Financial Officer | $530,963 | $3,949,075 |
| 2023 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Financial Officer | $496,654 | $3,737,235 |
| 2022 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Financial Officer | $469,093 | $3,546,148 |
| 2021 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Financial Officer | $452,692 | $3,075,916 |
| 2020 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Financial Officer | $430,269 | $3,485,149 |
| 2019 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Financial Officer | $386,423 | $1,719,303 |
| 2018 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Financial Officer | $380,000 | $859,752 |
| 2017 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Financial Officer | $68,939 | $2,296,699 |
Earnings-call appearances
-
Apellis Pharmaceuticals, Inc. Q3 FY2025 Earnings Call2025-09-30
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q2 FY2025 Earnings Call2025-06-30
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q1 FY2024 Earnings Call2024-03-31
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q3 FY2022 Earnings Call2022-09-30
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q2 FY2022 Earnings Call2022-06-30
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q1 FY2022 Earnings Call2022-03-31
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q2 FY2021 Earnings Call2021-06-30
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q1 FY2021 Earnings Call2021-03-31
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q4 FY2020 Earnings Call2020-12-31
Apellis Pharmaceuticals, Inc. (APLS)